These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1149 related articles for article (PubMed ID: 16621020)

  • 1. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
    Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y
    Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine efficacy and immune response to swine influenza virus challenge in pigs infected with porcine reproductive and respiratory syndrome virus at the time of SIV vaccination.
    Kitikoon P; Vincent AL; Jones KR; Nilubol D; Yu S; Janke BH; Thacker BJ; Thacker EL
    Vet Microbiol; 2009 Nov; 139(3-4):235-44. PubMed ID: 19595522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.
    Lee JH; Gramer MR; Joo HS
    Can J Vet Res; 2007 Jul; 71(3):207-12. PubMed ID: 17695596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.
    Gauger PC; Vincent AL; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA
    Vaccine; 2011 Mar; 29(15):2712-9. PubMed ID: 21310191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibody responses to swine influenza virus (SIV) recombinant matrix 1 (rM1), matrix 2 (M2), and hemagglutinin (HA) proteins in pigs with different SIV exposure.
    Kitikoon P; Strait EL; Thacker EL
    Vet Microbiol; 2008 Jan; 126(1-3):51-62. PubMed ID: 17719187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and subsequent cross-protection of influenza virus infection in pigs sustained by an H1N2 strain.
    Ferrari M; Borghetti P; Foni E; Robotti C; Di Lecce R; Corradi A; Petrini S; Bottarelli E
    Zoonoses Public Health; 2010 Jun; 57(4):273-80. PubMed ID: 19538454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
    Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of age and maternal antibodies on the postvaccinal response against swine influenza viruses in pigs.
    Markowska-Daniel I; Pomorska-Mól M; Pejsak Z
    Vet Immunol Immunopathol; 2011 Jul; 142(1-2):81-6. PubMed ID: 21501880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.
    Wesley RD; Tang M; Lager KM
    Vaccine; 2004 Sep; 22(25-26):3427-34. PubMed ID: 15308368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs.
    Platt R; Vincent AL; Gauger PC; Loving CL; Zanella EL; Lager KM; Kehrli ME; Kimura K; Roth JA
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):252-7. PubMed ID: 21664701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate.
    Kyriakis CS; Gramer MR; Barbé F; Van Doorsselaere J; Van Reeth K
    Vet Microbiol; 2010 Jul; 144(1-2):67-74. PubMed ID: 20116942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of maternally derived antibodies on the clinical signs and immune response in pigs after primary and secondary infection with an influenza H1N1 virus.
    Loeffen WL; Heinen PP; Bianchi AT; Hunneman WA; Verheijden JH
    Vet Immunol Immunopathol; 2003 Mar; 92(1-2):23-35. PubMed ID: 12628761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-fostering to prevent maternal cell transfer did not prevent vaccine-associated enhanced respiratory disease that occurred following heterologous influenza challenge of pigs vaccinated in the presence of maternal immunity.
    Loving CL; Brockmeier SL; Vincent AL; Gauger PC; Zanella EL; Lager KM; Kehrli ME
    Viral Immunol; 2014 Sep; 27(7):334-42. PubMed ID: 24978861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
    Reeth KV; Brown I; Essen S; Pensaert M
    Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental dual infection of pigs with an H1N1 swine influenza virus (A/Sw/Hok/2/81) and Mycoplasma hyopneumoniae.
    Yazawa S; Okada M; Ono M; Fujii S; Okuda Y; Shibata I; Kida H
    Vet Microbiol; 2004 Mar; 98(3-4):221-8. PubMed ID: 15036530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates.
    Kitikoon P; Vincent AL; Janke BH; Erickson B; Strait EL; Yu S; Gramer MR; Thacker EL
    Vaccine; 2009 Dec; 28(2):523-31. PubMed ID: 19837089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus.
    Li GX; Tian ZJ; Yu H; Jin YY; Hou SH; Zhou YJ; Liu TQ; Hu SP; Tong GZ
    Res Vet Sci; 2009 Jun; 86(3):406-13. PubMed ID: 19010505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.